Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a nonfunctional DNA sequence resembling a member of the DHHC-type zinc finger protein family, annotated as a pseudogene in the human genome (Ensembl ENSG00000251193). Pseudogenes typically result from gene duplication or retrotransposition events and accumulate mutations that disable their ability to encode functional proteins[3][5]. While some pseudogenes have regulatory roles at the RNA level, the majority are biologically inert and lack clinical significance. The designation "novel" here signals that this particular pseudogene is newly annotated or not well-characterized, with no evidence for protein-coding or relevant biological or disease associations. By molecular classification, it belongs to the pseudogene class and is not a therapeutic target, receptor, enzyme, transporter, or transcription factor[3][5].
Not a druggable target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DHHC-type zinc finger pseudogene.